BioMelbourne Network - Progressing BioIndustry

Biotechnology Melbourne - Industry Overview

Victoria, led by its capital Melbourne, is an innovative hub for world-class science.

In 2009, Victoria's life science industry is moving closer towards becoming one of the world's top five biotechnology locations.
Melbourne is home to:
- CSL Ltd - one of the world's top ten biotechnology companies.
- 50% of the top 20 biotechnology companies listed on the Australian Stock Exchange (ASX).
- Almost 75% of Australia's top biotechnology organisations by market capitalisation.
- 47 listed life science companies, which have a combined market capitalisation of A$22 billion as at December 2008.
In 2009, Melbourne's listed life science companies currently have 85 life science products on the market with 12 Phase III and 39 Phase II clinical trial programs underway.
In 2007-08, listed life science firms in Victoria generated export sales of around A$320 million, produced sales in excess of A$7.2 million and recorded an aggregate net profit of A$593 million.
In the last 10 years, the Victorian State Government has invested A$3.4 billion into science, technology and innovation. In 2008, the Victorian State Government announced a further A$300 million commitment to science, technology and innovation, bringing their total investment over 10 years to A$3.4 billion. They also committed a further A$78.8 million to the Victorian Cancer Agency - a dedicated agency to accelerate translational cancer research to deliver improved patient outcomes.